3 February 2023
SHARE NOW
ATW
Automation & Digitisation
Cell Therapy
Gene Therapy
Logistics
In this Tech Demo, Title21 describes how its Manufacturing Exertion System (MES), a powerful platform of integrated modules can supports autologous and allogeneic workflows.
Title21 demonstrates the applications of the MES cell manufacturing platform whilst showing how to navigate the integrated system built for ease of customer use.
The platform offers a shortened implementation time, reduced configuration efforts and lower workflow costs, whilst providing out-of-the-box modules for evolving protocols.
This demo has been produced in partnership with Title21.
 |
 |
More like this
Must-See Sessions at Advanced Therapies Week 2025: Ry Leahy, Head of Content, Phacilitate
Cell and gene therapies are set to revolutionize the future of medicine, but one of the major hurdles is the production of good quality cells cost-effectively and at scale
10 January 2025
ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies
We caught up with Patrick M Gailliot, Sr. Director, Patient Operations at Abeona Therapeutics, to talk to him about why his work gives him so much joy, preview his session at Advanced Therapies Week in Dallas, and explain the value he gets from the event.
26 November 2024
Texas Cell and Gene Manufacturing Landscape
Ahead of Advanced Therapies Week 2025 in Dallas, we take a look at the Texas cell and gene manufacturing landscape.
19 November 2024
